Metallothionein-3 increases triple-negative breast cancer cell invasiveness via induction of metalloproteinase expression

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Kmiecik, Alicja M ^a   Pula, Bartosz ^b   Suchanski, Jaroslaw ^c   Olbromski, Mateusz ^b   Gomulkiewicz, Agnieszka ^b   Owczarek, Tomasz ^a   Kruczak, Anna ^d   Ambicka, Aleksandra ^d   Rys, Janusz ^d   Ugorski, Maciej ^a,c   Podhorska Okolow, Marzena ^b   Dziegiel, Piotr ^b,e  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e UNIVERSITY OF WROC AW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; METALLOPROTEINASE; METALLOTHIONEIN III; PROGESTERONE RECEPTOR; STROMELYSIN; GROWTH INHIBITOR; NERVE PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; ENZYMOLOGY; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; SURVIVAL ANALYSIS; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 3; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84929105223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124865     Document Type: Article

References (38)

1. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci. 2002; 59: 627-647. PMID: 12022471
2. Dziegiel P. Expression of metallothioneins in tumor cells. Pol J Pathol. 2004; 55: 3-12. PMID: 15195701
3. Nielsen AE, Bohr A, Penkowa M. The Balance between Life and Death of Cells: Roles of Metallothioneins. Biomark Insights. 2007; 1: 99-111. PMID: 19690641
4. Pula B, Domoslawski P, Podhorska-Okolow M, Dziegiel P. Role of metallothioneins in benign and malignant thyroid lesions. Thyroid Res. 2012; 5: 26. doi: 10.1186/1756-6614-5-26 PMID: 23273222
5. Thirumoorthy N, Shyam Sunder A, Manisenthil Kumar K, Senthil Kumar M, Ganesh G, Chatterjee M. A review of metallothionein isoforms and their role in pathophysiology. World J Surg Oncol. 2011; 9: 54. doi: 10.1186/1477-7819-9-54 PMID: 21599891
6. Dziegiel P, Salwa-Zurawska W, Zurawski J, Wojnar A, Zabel M. Prognostic significance of augmented metallothionein (MT) expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas. Histol Histopathol. 2005; 20: 83-89. PMID: 15578426
7. Surowiak P, Matkowski R, Materna V, Gyorffy B, Wojnar A, Pudelko M, et al. Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance. Histol Histopathol. 2005; 20: 1037-1044. PMID: 16136485
8. Wojnar A, Pula B, Piotrowska A, Jethon A, Kujawa K, Kobierzycki C, et al. Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma. Anticancer Res. 2011; 31: 3027-3033. PMID: 21868554
9. Uchida Y, Tomonaga M. Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons. Brain Res. 1989; 481: 190-193. PMID: 2706462
10. Lee SJ, Koh JY. Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain. 2010; 3: 30. doi: 10.1186/1756-6606-3-30 PMID: 20974010
11. Garrett SH, Sens MA, Todd JH, Somji S, Sens DA. Expression of MT-3 protein in the human kidney. Toxicol Lett. 1999; 105: 207-214. PMID: 10355541
12. Hoey JG, Garrett SH, Sens MA, Todd JH, Sens DA. Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma. Toxicol Lett. 1997; 92: 149-160. PMID: 9295238
13. Garrett SH, Sens MA, Shukla D, Nestor S, Somji S, Todd JH, et al. Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines. Prostate. 1999; 41: 196-202. PMID: 10517878
14. Sens MA, Somji S, Lamm DL, Garrett SH, Slovinsky F, Todd JH, et al. Metallothionein isoform 3 as a potential biomarker for human bladder cancer. Environ Health Perspect. 2000; 108: 413-418. PMID: 10852838
15. Somji S, Garrett SH, Zhou XD, Zheng Y, Sens DA, Sens MA. Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control. Toxicol Environ Chem. 2010; 92: 1673-1695. PMID: 21170156
16. Werynska B, Pula B, Muszczynska-Bernhard B, Gomulkiewicz A, Jethon A, Podhorska-Okolow M, et al. Expression of metallothionein-III in patients with non-small cell lung cancer. Anticancer Res. 2013; 33: 965-974. PMID: 23482768
17. Deng D, El-Rifai W, Ji J, Zhu B, Trampont P, Li J, et al. Hypermethylation of metallothionein-3 CpG island in gastric carcinoma. Carcinogenesis. 2003; 24: 25-29. PMID: 12538345
18. Smith E, Drew PA, Tian ZQ, De Young NJ, Liu JF, Mayne GC, et al. Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol Cancer. 2005; 4: 42. PMID: 16351731
19. Peng D, Hu TL, Jiang A, Washington MK, Moskaluk CA, Schneider-Stock R, et al. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS One. 2011; 6: e22009. doi: 10.1371/journal.pone.0022009 PMID: 21818286
20. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J. 1992; 11: 4843-4850. PMID: 1464312
21. Amoureux MC, Wurch T, Pauwels PJ. Modulation of metallothionein-III mRNA content and growth rate of rat C6-glial cells by transfection with human 5-HT1D receptor genes. Biochem Biophys Res Commun. 1995; 214: 639-645. PMID: 7677777
22. Gurel V, Sens DA, Somji S, Garrett SH, Nath J, Sens MA. Stable transfection and overexpression of metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T cells but not that of T-47D or MDA-MB- 231 cells. Breast Cancer Res Treat. 2003; 80: 181-191. PMID: 12908821
23. Dutta R, Sens DA, Somji S, Sens MA, Garrett SH. Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells. Prostate. 2002; 52: 89-97. PMID: 12111700
24. Juang HH, Chung LC, Sung HC, Feng TH, Lee YH, Chang PL, et al. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. Prostate. 2013; 73: 1495-1506. doi: 10.1002/pros.22697 PMID: 23794209
25. Peyruchaud O, Winding B, Pecheur I, Serre CM, Delmas P, Clezardin P. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions. J Bone Miner Res. 2001; 16: 2027-2034. PMID: 11697798
26. Elston CW. Grading of invasvie carcinoma of the breast. In: Page D. L. TJA, editor. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone. 1987. pp. 300-311.
27. Kobierzycki C, Pula B, Wojnar A, Podhorska-Okolow M, Dziegiel P. Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer. Anticancer Res. 2012; 32: 773-777. PMID: 22399591
28. Kim HG, Kim JY, Han EH, Hwang YP, Choi JH, Park BH, et al. Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. FEBS Lett. 2011; 585: 421-428. doi: 10.1016/j.febslet.2010.12.030 PMID: 21187089
29. Sens MA, Somji S, Garrett SH, Beall CL, Sens DA. Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. Am J Pathol. 2001; 159: 21-26. PMID: 11438449
30. Pedersen MO, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem. 2009; 44: 29-64. doi: 10.1016/j.proghi.2008.10.001 PMID: 19348910
31. Krizkova S, Ryvolova M, Hrabeta J, Adam V, Stiborova M, Eckschlager T, et al. Metallothioneins and zinc in cancer diagnosis and therapy. Drug Metab Rev. 2012; 44: 287-301. doi: 10.3109/03602532. 2012.725414 PMID: 23050852
32. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 1991; 7: 337-347. PMID: 1873033
33. Asai M, Kato M, Asai N, Iwashita T, Murakami H, Kawai K, et al. Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice. Jpn J Cancer Res. 1999; 90: 86-92. PMID: 10076570
34. Gobel H, van der Wal AC, Teeling P, van der Loos CM, Becker AE. Metallothionein in human atherosclerotic lesions: a scavenger mechanism for reactive oxygen species in the plaque? Virchows Arch. 2000; 437: 528-533. PMID: 11147174
35. Zitka O, Krizkova S, Huska D, Adam V, Hubalek J, Eckschlager T, et al. Chip gel electrophoresis as a tool for study of matrix metalloproteinase 9 interaction with metallothionein. Electrophoresis. 2011; 32: 857-860. doi: 10.1002/elps.201000526 PMID: 21425178
36. Person RJ, Tokar EJ, Xu Y, Orihuela R, Ngalame NN, Waalkes MP. Chronic cadmium exposure in vitro induces cancer cell characteristics in human lung cells. Toxicol Appl Pharmacol. 2013; 273: 281-288. doi: 10.1016/j.taap.2013.06.013 PMID: 23811327
37. Ryu HH, Jung S, Jung TY, Moon KS, Kim IY, Jeong YI, et al. Role of metallothionein 1E in the migration and invasion of human glioma cell lines. Int J Oncol. 2012; 41: 1305-1313. doi: 10.3892/ijo.2012.1570 PMID: 22843066
38. Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell. 2011; 147: 992-1009. doi: 10.1016/j.cell.2011.11.016 PMID: 22118458